Taiwan-based healthtech startup Deep01 has secured around $2.7 million in a fresh funding round led by global electronics manufacturer AsusTeK, the media reported.
Other investors that participated in the funding round for Deep01 include BE Capital and Digital Economy Fund, co-funded by the Industrial Technology Research Institute and the Institute for Information Industry.
The startup develops artificial intelligence (AI) software designed to help physicians interpret computerized tomography (CT) images of the brain.
According to Deep01, its product can detect acute intracerebral hemorrhage (ICH) – a type of stroke – for accident and emergency (A&E) departments with an accuracy of 93 percent to 95 percent at 30 seconds per case.
The startup is also the first AI company in APAC to obtain US-FDA clearances in July 2019.
With regard to the funding in Deep01, Arthur Chen, managing director of BE Capital told the media, “Deep01 is a member of the BE supporting program. The system is in the Show Chwan hospital, and profitable results are already present. The AI emergency network has potential in the overseas markets. We introduced the company to the authorities in Japan, and the integration will proceed in the second half of this year.”
According to Deep01 founder and chief executive officer David Chou, the ICT and healthcare industries in Taiwan are competitive on the international stage, and successful cases of commercialisation will make Deep01’s product more feasible in the global market.
Reportedly, Deep01 also received Taiwan’s FDA clearance for its AI product of ICH in February 2020 and received its first purchase order of $0.7 million.